BCHE and early-onset autosomal dominant Alzheimer disease: The recently reported cholinesterase inhibitory activity of the essential oil and extracts of C. maritimum L. represents an important target in the treatment of the first stage of Alzheimer’s disease, dementia, and other neurological disorders [7,8].